Skip to main content
OpenTrials

Clinical trial condition

Acromegaly

Explore clinical trials studying Acromegaly. Study availability and eligibility vary by location and protocol.

138 public trials 10 recruiting studies
Refine in advanced search Browse all conditions

Acromegaly trial results

Completed

Safety, Tolerability, and Efficacy of IONIS-GHR-LRx in Participants With Acromegaly Being Treated With Long-acting Somatostatin Receptor Ligands

NCT03548415

Conditions
Acromegaly, Bone Diseases, Bone Diseases, Endocrine, +8 more
Locations
  • University of Alabama at Birmingham (UAB) Birmingham, Alabama, United States
  • St. Joseph's Hospital and Medical Center Phoenix, Arizona, United States
  • Northwestern University Chicago, Illinois, United States
  • Palm Research Center, Inc. Las Vegas, Nevada, United States
View all 33 locations
View Trial Details
Completed

Lanreotide as Primary Treatment for Acromegalic Patients With Pituitary Gland Macroadenoma

NCT00690898

Conditions
Acromegaly, Bone Diseases, Bone Diseases, Endocrine, +8 more
Locations
  • University Hospital Antwerpen Edegem, Belgium
  • Všeobecná fakultní nemocnice, Karlova Univerzita Prague, Czechia
  • Helsinki University Center Hospital Helsinki, Finland
  • The Turku University Central Hospital Turku, Finland
View all 27 locations
View Trial Details
Completed

Lanreotide Autogel and Pegvisomant Combination Therapy in Acromegalic Patients

NCT00383708

Conditions
Acromegaly, Bone Diseases, Bone Diseases, Endocrine, +8 more
Locations
  • University Hospital, Charles University Hradec Králové, Czechia
  • Charles University Prague, Czechia
  • Aarhus Kommunehospital Aarhus, Denmark
  • Groupe Hospitalier Henri Mondor- Albert Chenevier Créteil, France
View all 24 locations
View Trial Details
Completed

Comparison of Oral Octreotide Capsules to Injectable Somatostatin Analogs in Acromegaly

NCT02685709

Conditions
Acromegaly, Bone Diseases, Bone Diseases, Endocrine, +8 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Keck Medical Center of University of Southern California Los Angeles, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Stanford University School of Medicine Stanford, California, United States
View all 53 locations
View Trial Details
Completed

Strict IGF-1 Control in Acromegaly

NCT02952885

Conditions
Acromegaly, Bone Diseases, Bone Diseases, Endocrine, +8 more
Locations
  • University of Alberta Hospital Edmonton, Alberta, Canada
  • St. Joseph Health Care London London, Ontario, Canada
  • The Ottawa Hospital Ottawa, Ontario, Canada
  • McGill University Health Centre Montreal, Quebec, Canada
View Trial Details
Completed

An Extension Study to Assess the Long-Term Safety and Efficacy of Pasireotide in Participants With Acromegaly

NCT00171730

Conditions
Acromegaly, Bone Diseases, Bone Diseases, Endocrine, +8 more
Locations
  • Cedars Sinai Medical Center Dept. of Pituitary Ctr. Los Angeles, California, United States
  • University of Michigan Health System StudyCoordinatorCSOM230B2201E1 Ann Arbor, Michigan, United States
  • NYU / VA Medical Center New York, United States
  • Novartis Investigative Site Woolloongabba, Queensland, Australia
View Trial Details
Completed

Study of Pasireotide Long Acting Release (LAR) Injection in Patients With Acromegaly and Patients With Carcinoid Disease

NCT00446082

Conditions
Acromegaly, Adenocarcinoma, Bone Diseases, +18 more
Locations
  • Cedars Sinai Medical Center SC - 4 Los Angeles, California, United States
  • Stanford University Medical Center Stanford Cancer Center (3) Stanford, California, United States
  • H. Lee Moffitt Cancer Center & Research Institute Dept.of H.LeeMoffittCC&RI(1) Tampa, Florida, United States
  • University of Texas/MD Anderson Cancer Center Gastrointestinal Med. Oncology Houston, Texas, United States
View all 17 locations
View Trial Details

Related conditions